Review of pharmacotherapy for smoking cessation in patients with schizophrenia

Review of pharmacotherapy for smoking cessation in patients with schizophrenia

Smoking cessation is a chronic issue surrounding individuals with schizophrenia. It is estimated that up to 90% of patients diagnosed with schizophrenia smoke cigarettes. The purpose of this article is to provide a nonsystematic review of the efficacy of smoking cessation interventions as well as to...

Full description

Saved in:
Bibliographic Details
Published in:The mental health clinician Vol. 8; no. 2; pp. 78 - 85
Main Authors: Shawen, Avery E, Drayton, Shannon J
Format: Journal Article
Language:English
Published: United States College of Psychiatric & Neurologic Pharmacists 01-03-2018
Subjects:
Review of Pharmacotherapy
varenicline
schizophrenia
nicotine replacement therapy
smoking cessation
bupropion
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Smoking cessation is a chronic issue surrounding individuals with schizophrenia. It is estimated that up to 90% of patients diagnosed with schizophrenia smoke cigarettes. The purpose of this article is to provide a nonsystematic review of the efficacy of smoking cessation interventions as well as to explore the potential neuropsychiatric adverse effects of these agents in patients with schizophrenia. Eighteen studies were found and included in the review. Overall, nicotine replacement therapy, bupropion, and varenicline have all proven their effectiveness at either promoting smoking abstinence or a significant reduction in cigarette use.
AbstractList Smoking cessation is a chronic issue surrounding individuals with schizophrenia. It is estimated that up to 90% of patients diagnosed with schizophrenia smoke cigarettes. The purpose of this article is to provide a nonsystematic review of the efficacy of smoking cessation interventions as well as to explore the potential neuropsychiatric adverse effects of these agents in patients with schizophrenia. Eighteen studies were found and included in the review. Overall, nicotine replacement therapy, bupropion, and varenicline have all proven their effectiveness at either promoting smoking abstinence or a significant reduction in cigarette use.
Author Shawen, Avery E
Drayton, Shannon J
Author_xml – sequence: 1
  givenname: Avery E
  orcidid: 0000-0002-6634-918X
  surname: Shawen
  fullname: Shawen, Avery E
  email: aeshawen@gmail.com
  organization: Student, Medical University of South Carolina College of Pharmacy, Charleston, South Carolina, aeshawen@gmail.com
– sequence: 2
  givenname: Shannon J
  orcidid: 0000-0001-5957-2642
  surname: Drayton
  fullname: Drayton, Shannon J
  organization: Associate Professor, Medical University of South Carolina College of Pharmacy, Charleston, South Carolina
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29955550$$D View this record in MEDLINE/PubMed
BookMark eNpVUU1LAzEQDaLYWj17kxy9tM4m3U32Ioj4BaIgeg5pduJGu8mabBX99Ub8oM5lBubNm8d7O2TTB4-E7Bcwq8UcjrrWzBgUcgZ8BkJukDErKjmtBdSba_OI7KX0BAAZOy-repuMWF2XuWBMbu7w1eEbDZb2rY6dNmFoMer-ndoQaerCs_OP1GBKenDBU-dpnyf0Q6JvbmhpMq37CH0b0Tu9S7asXibc--kT8nB-dn96Ob2-vbg6PbmeGsZllsUWugQmG8FMAQLtvBRNaSpeN42sOG_KuTB6Ia0thDRaM2k1lhLEAtHyxvIJOf7m7VeLDhuT5US9VH10nY7vKmin_m-8a9VjeFUVgMjeZYLDH4IYXlaYBtW5ZHC51B7DKikGFZNMCFZn6NE31MSQUkT796YA9RWEykGoryAUcJWDyBcH6-r-8L-280-x7oi-
CitedBy_id crossref_primary_10_1016_j_scog_2018_09_003
crossref_primary_10_1097_JCP_0000000000001170
crossref_primary_10_1016_j_ajp_2020_102190
crossref_primary_10_1007_s00406_020_01186_z
crossref_primary_10_1016_j_ajp_2020_102530
crossref_primary_10_1016_j_mcna_2022_07_008
crossref_primary_10_1177_0897190020904280
crossref_primary_10_1002_wps_20809
crossref_primary_10_1097_YCO_0000000000000529
crossref_primary_10_3389_fpsyt_2023_1142419
crossref_primary_10_1080_14656566_2020_1721466
Cites_doi 10.4088/JCP.11m07522
10.1097/JCP.0b013e3182870551
10.1016/j.schres.2011.02.003
10.1192/apt.6.5.327
10.1001/jama.2013.285113
10.1016/j.biopsych.2007.11.002
10.1136/bmj.328.7438.509
10.4088/JCP.10m06143gre
10.1016/j.schres.2013.02.015
10.1080/14622200110073920
10.1016/j.drugalcdep.2009.04.005
10.1097/01.jcp.0000162802.54076.18
10.1371/journal.pone.0143490
10.1016/j.schres.2004.01.006
10.1016/j.schres.2005.02.021
10.4088/JCP.v65n0304
10.1007/s00406-012-0338-3
10.1007/s00213-011-2282-8
10.3390/ijerph10020446
10.3389/fnins.2015.00297
10.1176/appi.ajp.157.11.1835
10.1016/S0140-6736(16)30272-0
10.1016/j.schres.2010.10.030
10.1016/S0893-133X(96)00018-8
10.2146/ajhp060428
10.1016/j.ijnurstu.2003.07.001
10.1016/S0006-3223(02)01339-2
10.1037/0022-006X.74.6.1153
10.1001/jamapsychiatry.2015.1737
10.1176/ps.50.10.1346
10.1097/01.jcp.0b013e3180ca86fa
ContentType Journal Article
Copyright 2018 CPNP. 2018
Copyright_xml – notice: 2018 CPNP. 2018
DBID NPM
AAYXX
CITATION
7X8
5PM
DOI 10.9740/mhc.2018.03.078
DatabaseName PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed

CrossRef
DeliveryMethod fulltext_linktorsrc
EISSN 2168-9709
EndPage 85
ExternalDocumentID 10_9740_mhc_2018_03_078
29955550
Genre Journal Article
Review
GroupedDBID ADBBV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
GROUPED_DOAJ
HYE
M~E
NPM
OK1
RPM
Y3D
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c2388-92ba5028d72c107ef457d5c639dd8633d547cab8ff178caa28fae5807beef3df3
IEDL.DBID RPM
ISSN 2168-9709
IngestDate Fri Sep 01 02:27:57 EDT 2023
Fri Apr 12 04:27:23 EDT 2024
Fri Nov 22 01:21:09 EST 2024
Wed Oct 16 00:59:45 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords varenicline
schizophrenia
nicotine replacement therapy
smoking cessation
bupropion
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2388-92ba5028d72c107ef457d5c639dd8633d547cab8ff178caa28fae5807beef3df3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ORCID 0000-0001-5957-2642
0000-0002-6634-918X
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007740/
PMID 29955550
PQID 2062827729
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6007740
proquest_miscellaneous_2062827729
crossref_primary_10_9740_mhc_2018_03_078
pubmed_primary_29955550
PublicationCentury 2000
PublicationDate 2018-Mar
PublicationDateYYYYMMDD 2018-03-01
PublicationDate_xml – month: 03
  year: 2018
  text: 2018-Mar
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The mental health clinician
PublicationTitleAlternate Ment Health Clin
PublicationYear 2018
Publisher College of Psychiatric & Neurologic Pharmacists
Publisher_xml – name: College of Psychiatric & Neurologic Pharmacists
References Bupropion (2020060307272336600_i2168-9709-8-2-78-b12) 2004; 328
Olfson (2020060307272336600_i2168-9709-8-2-78-b10) 2015; 72
Evins (2020060307272336600_i2168-9709-8-2-78-b29) 2014; 311
Weiner (2020060307272336600_i2168-9709-8-2-78-b26) 2011; 129
2020060307272336600_i2168-9709-8-2-78-b03
Smith (2020060307272336600_i2168-9709-8-2-78-b27) 2016; 11
Fatemi (2020060307272336600_i2168-9709-8-2-78-b34) 2013; 146
2020060307272336600_i2168-9709-8-2-78-b01
2020060307272336600_i2168-9709-8-2-78-b02
Ventriglio (2020060307272336600_i2168-9709-8-2-78-b09) 2015; 9
Potts (2020060307272336600_i2168-9709-8-2-78-b13) 2007; 64
Evins (2020060307272336600_i2168-9709-8-2-78-b32) 2007; 27
(2020060307272336600_i2168-9709-8-2-78-b38) 2016
George (2020060307272336600_i2168-9709-8-2-78-b33) 2008; 63
Weiner (2020060307272336600_i2168-9709-8-2-78-b22) 2012; 73
Dolan (2020060307272336600_i2168-9709-8-2-78-b05) 2004; 70
Fatemi (2020060307272336600_i2168-9709-8-2-78-b20) 2005; 76
(2020060307272336600_i2168-9709-8-2-78-b36) 2009
George (2020060307272336600_i2168-9709-8-2-78-b35) 2000; 157
Caponnetto (2020060307272336600_i2168-9709-8-2-78-b39) 2013; 10
2020060307272336600_i2168-9709-8-2-78-b15
Chou (2020060307272336600_i2168-9709-8-2-78-b14) 2004; 41
Levin (2020060307272336600_i2168-9709-8-2-78-b40) 1996; 15
Ferguson (2020060307272336600_i2168-9709-8-2-78-b11) 2006; 74
Anthenelli (2020060307272336600_i2168-9709-8-2-78-b37) 2016; 387
Evins (2020060307272336600_i2168-9709-8-2-78-b19) 2004; 65
Mann-Wrobel (2020060307272336600_i2168-9709-8-2-78-b06) 2011; 126
Williams (2020060307272336600_i2168-9709-8-2-78-b31) 2012; 73
Evins (2020060307272336600_i2168-9709-8-2-78-b23) 2005; 25
Chen (2020060307272336600_i2168-9709-8-2-78-b17) 2013; 263
Kelly (2020060307272336600_i2168-9709-8-2-78-b08) 2000; 6
George (2020060307272336600_i2168-9709-8-2-78-b18) 2002; 52
Meszaros (2020060307272336600_i2168-9709-8-2-78-b28) 2013; 33
Evins (2020060307272336600_i2168-9709-8-2-78-b24) 2001; 3
Castle (2020060307272336600_i2168-9709-8-2-78-b30) 2012; 24
Tidey (2020060307272336600_i2168-9709-8-2-78-b21) 2011; 217
(2020060307272336600_i2168-9709-8-2-78-b25) 2009
Moss (2020060307272336600_i2168-9709-8-2-78-b07) 2009; 104
Lyon (2020060307272336600_i2168-9709-8-2-78-b04) 1999; 50
Dale Horst (2020060307272336600_i2168-9709-8-2-78-b16) 2005; 1
References_xml – volume: 73
  start-page: 654
  issue: 5
  year: 2012
  ident: 2020060307272336600_i2168-9709-8-2-78-b31
  article-title: A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.11m07522
  contributor:
    fullname: Williams
– volume: 33
  start-page: 243
  issue: 2
  year: 2013
  ident: 2020060307272336600_i2168-9709-8-2-78-b28
  article-title: Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial
  publication-title: J Clin Psychopharmacol
  doi: 10.1097/JCP.0b013e3182870551
  contributor:
    fullname: Meszaros
– volume: 129
  start-page: 94
  issue: 1
  year: 2011
  ident: 2020060307272336600_i2168-9709-8-2-78-b26
  article-title: Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2011.02.003
  contributor:
    fullname: Weiner
– volume: 6
  start-page: 327
  issue: 5
  year: 2000
  ident: 2020060307272336600_i2168-9709-8-2-78-b08
  article-title: Cigarette smoking and schizophrenia
  publication-title: Adv Psychiatric Treat
  doi: 10.1192/apt.6.5.327
  contributor:
    fullname: Kelly
– year: 2009
  ident: 2020060307272336600_i2168-9709-8-2-78-b25
  article-title: Wellbutrin XL [package insert]
– volume: 311
  start-page: 145
  issue: 2
  year: 2014
  ident: 2020060307272336600_i2168-9709-8-2-78-b29
  article-title: Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial
  publication-title: JAMA
  doi: 10.1001/jama.2013.285113
  contributor:
    fullname: Evins
– volume: 63
  start-page: 1092
  issue: 11
  year: 2008
  ident: 2020060307272336600_i2168-9709-8-2-78-b33
  article-title: A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2007.11.002
  contributor:
    fullname: George
– volume: 328
  start-page: 509
  issue: 7438
  year: 2004
  ident: 2020060307272336600_i2168-9709-8-2-78-b12
  article-title: and other non-nicotine pharmacotherapies
  publication-title: BMJ
  doi: 10.1136/bmj.328.7438.509
  contributor:
    fullname: Bupropion
– volume: 73
  start-page: 95
  issue: 1
  year: 2012
  ident: 2020060307272336600_i2168-9709-8-2-78-b22
  article-title: Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.10m06143gre
  contributor:
    fullname: Weiner
– volume: 146
  start-page: 376
  issue: 1-3
  year: 2013
  ident: 2020060307272336600_i2168-9709-8-2-78-b34
  article-title: Antismoking and potential antipsychotic effects of varenicline in subjects with schizophrenia or schizoaffective disorder: a double-blind placebo and bupropion-controlled study
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2013.02.015
  contributor:
    fullname: Fatemi
– volume: 3
  start-page: 397
  issue: 4
  year: 2001
  ident: 2020060307272336600_i2168-9709-8-2-78-b24
  article-title: A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia
  publication-title: Nicotine Tob Res
  doi: 10.1080/14622200110073920
  contributor:
    fullname: Evins
– volume: 104
  start-page: 94
  issue: 1-2
  year: 2009
  ident: 2020060307272336600_i2168-9709-8-2-78-b07
  article-title: Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia
  publication-title: Drug Alcohol Depend
  doi: 10.1016/j.drugalcdep.2009.04.005
  contributor:
    fullname: Moss
– volume: 25
  start-page: 218
  issue: 3
  year: 2005
  ident: 2020060307272336600_i2168-9709-8-2-78-b23
  article-title: A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia
  publication-title: J Clin Psychopharmacol
  doi: 10.1097/01.jcp.0000162802.54076.18
  contributor:
    fullname: Evins
– volume: 11
  start-page: e0143490
  issue: 1
  year: 2016
  ident: 2020060307272336600_i2168-9709-8-2-78-b27
  article-title: Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia: A double-blind randomized trial
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0143490
  contributor:
    fullname: Smith
– volume: 70
  start-page: 263
  issue: 2-3
  year: 2004
  ident: 2020060307272336600_i2168-9709-8-2-78-b05
  article-title: Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2004.01.006
  contributor:
    fullname: Dolan
– volume: 76
  start-page: 353
  issue: 2-3
  year: 2005
  ident: 2020060307272336600_i2168-9709-8-2-78-b20
  article-title: A double-blind placebo-controlled cross over trial of bupropion in smoking reduction in schizophrenia
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2005.02.021
  contributor:
    fullname: Fatemi
– volume: 1
  start-page: 349
  issue: 4
  year: 2005
  ident: 2020060307272336600_i2168-9709-8-2-78-b16
  article-title: Extended use of nicotine replacement therapy to maintain smoking cessation in persons with schizophrenia
  publication-title: Neuropsychiatr Dis Treat
  contributor:
    fullname: Dale Horst
– volume: 65
  start-page: 307
  issue: 3
  year: 2004
  ident: 2020060307272336600_i2168-9709-8-2-78-b19
  article-title: Two-year follow-up of a smoking cessation trial in patients with schizophrenia
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.v65n0304
  contributor:
    fullname: Evins
– volume: 263
  start-page: 75
  year: 2013
  ident: 2020060307272336600_i2168-9709-8-2-78-b17
  article-title: A double-blind randomized clinical trial of different doses of transdermal nicotine patch for smoking reduction and cessation in long-term hospitalized schizophrenic patients
  publication-title: Eur Arch Psychiatry Clin Neurosci
  doi: 10.1007/s00406-012-0338-3
  contributor:
    fullname: Chen
– volume: 217
  start-page: 279
  issue: 2
  year: 2011
  ident: 2020060307272336600_i2168-9709-8-2-78-b21
  article-title: Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia
  publication-title: Psychopharmacology
  doi: 10.1007/s00213-011-2282-8
  contributor:
    fullname: Tidey
– volume: 10
  start-page: 446
  issue: 2
  year: 2013
  ident: 2020060307272336600_i2168-9709-8-2-78-b39
  article-title: Impact of an electronic cigarette on smoking reduction and cessation in schizophrenic smokers: a prospective 12-month pilot study
  publication-title: Int J Environ Res Public Health
  doi: 10.3390/ijerph10020446
  contributor:
    fullname: Caponnetto
– volume: 9
  start-page: 297
  year: 2015
  ident: 2020060307272336600_i2168-9709-8-2-78-b09
  article-title: Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management
  publication-title: Front Neurosci
  doi: 10.3389/fnins.2015.00297
  contributor:
    fullname: Ventriglio
– ident: 2020060307272336600_i2168-9709-8-2-78-b01
  article-title: Current cigarette smoking among adults in the United States [Internet]
  publication-title: Centers for Disease Control and Prevention, 2016 [cited 2016 Jun 14]
– year: 2009
  ident: 2020060307272336600_i2168-9709-8-2-78-b36
  article-title: Chantix (varenicline tablets) [package insert]
– ident: 2020060307272336600_i2168-9709-8-2-78-b03
  article-title: Nicotine dependence in schizophrenia: Prevalence, mechanisms, and implications for treatment [Internet]
  publication-title: Psychiatric Times, 2008
– volume: 157
  start-page: 1835
  issue: 11
  year: 2000
  ident: 2020060307272336600_i2168-9709-8-2-78-b35
  article-title: Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia
  publication-title: Am J Psychiatry
  doi: 10.1176/appi.ajp.157.11.1835
  contributor:
    fullname: George
– year: 2016
  ident: 2020060307272336600_i2168-9709-8-2-78-b38
  article-title: FDA removes black box warning from Varenicline's label [Internet]
  publication-title: New England Journal of Medicine
– volume: 387
  start-page: 2507
  issue: 10037
  year: 2016
  ident: 2020060307272336600_i2168-9709-8-2-78-b37
  article-title: Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(16)30272-0
  contributor:
    fullname: Anthenelli
– volume: 126
  start-page: 277
  issue: 1-3
  year: 2011
  ident: 2020060307272336600_i2168-9709-8-2-78-b06
  article-title: Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2010.10.030
  contributor:
    fullname: Mann-Wrobel
– volume: 15
  start-page: 429
  issue: 5
  year: 1996
  ident: 2020060307272336600_i2168-9709-8-2-78-b40
  article-title: Nicotine-haloperidol interactions and cognitive performance in schizophrenics
  publication-title: Neuropsychopharmacology
  doi: 10.1016/S0893-133X(96)00018-8
  contributor:
    fullname: Levin
– ident: 2020060307272336600_i2168-9709-8-2-78-b02
  article-title: Smoking among adults with mental illness [Internet]
  publication-title: Centers for Disease Control and Prevention, 2013
– volume: 64
  start-page: 1381
  issue: 13
  year: 2007
  ident: 2020060307272336600_i2168-9709-8-2-78-b13
  article-title: Varenicline: The newest agent for smoking cessation
  publication-title: Am J Health Syst Pharm
  doi: 10.2146/ajhp060428
  contributor:
    fullname: Potts
– volume: 41
  start-page: 321
  issue: 3
  year: 2004
  ident: 2020060307272336600_i2168-9709-8-2-78-b14
  article-title: The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia
  publication-title: Int J Nurs Stud
  doi: 10.1016/j.ijnurstu.2003.07.001
  contributor:
    fullname: Chou
– volume: 52
  start-page: 53
  issue: 1
  year: 2002
  ident: 2020060307272336600_i2168-9709-8-2-78-b18
  article-title: A placebo controlled trial of bupropion for smoking cessation in schizophrenia
  publication-title: Biol Psychiatry
  doi: 10.1016/S0006-3223(02)01339-2
  contributor:
    fullname: George
– volume: 74
  start-page: 1153
  year: 2006
  ident: 2020060307272336600_i2168-9709-8-2-78-b11
  article-title: Does reducing withdrawal severity mediate nicotine patch efficacy? A randomized clinical trial
  publication-title: J Consult Clin Psychol
  doi: 10.1037/0022-006X.74.6.1153
  contributor:
    fullname: Ferguson
– volume: 72
  start-page: 1172
  issue: 12
  year: 2015
  ident: 2020060307272336600_i2168-9709-8-2-78-b10
  article-title: Premature mortality among adults with schizophrenia in the United States
  publication-title: JAMA Psychiatry
  doi: 10.1001/jamapsychiatry.2015.1737
  contributor:
    fullname: Olfson
– volume: 50
  start-page: 1346
  issue: 10
  year: 1999
  ident: 2020060307272336600_i2168-9709-8-2-78-b04
  article-title: A review of the effects of nicotine on schizophrenia and antipsychotic medications
  publication-title: Psychiatr Serv
  doi: 10.1176/ps.50.10.1346
  contributor:
    fullname: Lyon
– volume: 24
  start-page: 285
  issue: 4
  year: 2012
  ident: 2020060307272336600_i2168-9709-8-2-78-b30
  article-title: Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders
  publication-title: Ann Clin Psychiatry
  contributor:
    fullname: Castle
– ident: 2020060307272336600_i2168-9709-8-2-78-b15
  article-title: Breath Carbon Monoxide Monitor - the stethoscope of smoking cessation [Internet]
  publication-title: coVita
– volume: 27
  start-page: 380
  issue: 4
  year: 2007
  ident: 2020060307272336600_i2168-9709-8-2-78-b32
  article-title: A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia
  publication-title: J Clin Psychopharmacol
  doi: 10.1097/01.jcp.0b013e3180ca86fa
  contributor:
    fullname: Evins
SSID ssj0002014569
Score 2.0723023
SecondaryResourceType review_article
Snippet Smoking cessation is a chronic issue surrounding individuals with schizophrenia. It is estimated that up to 90% of patients diagnosed with schizophrenia smoke...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 78
SubjectTerms Review of Pharmacotherapy
Title Review of pharmacotherapy for smoking cessation in patients with schizophrenia
URI https://www.ncbi.nlm.nih.gov/pubmed/29955550
https://search.proquest.com/docview/2062827729
https://pubmed.ncbi.nlm.nih.gov/PMC6007740
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZoJxYE4hUelZEYWNI6D8fuiEqrLlRIgMQWOX6oRSStCB3499zlUbWwkTWOZX05-b47330m5FbbJNaWZz5Kw_ixDbifBcz5zljDnOZGCOxGnj6L2Zt8GKNMDm97YaqifZ0t-sVH3i8W86q2cpXrQVsnNnh6HKGmuojZoEM6wA23QvT36mQtAFIwrGV8hjgsn6NWYSArNVOBN_TBHszhYbvO6A_D_F0oueV5JofkoKGM9L5e2hHZs8UxmdVJfbp0dNWoT9etVN8UaCgt8yXmwCk2AVTY00VBGw3VkmLylZbb5XYn5HUyfhlN_eZuBF-Dk4U9KswUB25gRKghgrMu5sJwDXzDGJlEkeGx0CqTzgVCaqVC6ZTlkonMWhcZF52SbrEs7DmhQKhQdQ-mEOCqwjiTlqnEssQqpkwUeOSuBSld1RIYKYQOCG0K0KYIbcqiFKD1yE0LYgpmimcPqrDLdQmDEgjukMp75KwGdTNZ-zc8Inbg3gxACezdN2AZlRR2YwkX__7ykuzj-uuqsivS_fpc22vSKc26V4Xnvcq4fgA6hdbw
link.rule.ids 230,315,729,782,786,866,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xHODCIrayGokDl1CnieNwRIWqiFIhARK3yPGiFtG0IvTA3zOTpWrhRq5elPg5njf2zDPAhbZRqK1IPZKG8ULrCy_1ufOcsYY7LYyUlI3cfZb9t_j2jmRyRJ0LUwTt63R4lX2MrrLhoIitnIx0s44Taz49tklTXYa8uQyr-L9yPuekvxdnaz7SgutSyOeaKo4GpFbox4WeqaQ7-nAVFvjwRXP0h2P-DpWcsz2dzX--9RZsVGST3ZTF27Bksx3ol8cBbOzYpNKtLpOwvhkSWJaPxrR7zih9oECNDTNWqa_mjLZtWT4fqLcLr527l3bXq25V8DSaZ1zdWqkSyCqMbGn0_awLhTRCI1MxJo6CwIhQapXGzvky1kq1YqesiLlMrXWBccEerGTjzB4AQypGen3YhUQj1wrT2HIVWR5ZxZUJ_AZc1oObTErxjASdDoIkQUgSgiThQYKQNOC8HvwEJzidWqjMjqc5VorQLSQnoAH7JRizzmoUGyAXYJpVIPHsxRJEpxDRrtA4_HfLM1jrvjz2kt59_-EI1ulbyti0Y1j5-pzaE1jOzfS0mJo_ITDrew
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwEB2xSIgLi9jKaiQOXEKdxXE4okJVBFRIgMQtcryoRTStCD3w98wkadXCDXLNxEr8HM8bz_gZ4EzbONJWZB5Jw3iR9YWX-dx5zljDnRZGStqN3HmS3dfk-oZkcqZHfZVF-zrrX-Tvg4u83ytrK0cD3ZzUiTUfH1qkqS4j3hwZ11yEZfxneTATqL-V-TUfqcFlJeZzScaDHikW-kmpaSrpnD6ciQVefN4l_eKZP8slZ_xPe_0fb74BazXpZFeVySYs2HwLulVagA0dG9X61dVmrC-GRJYVgyGtojPaRlCix_o5q1VYC0bLt6yYLdjbhpf2zXOr49WnK3ga3TTOckGmBLILIwONMaB1kZBGaGQsxiRxGBoRSa2yxDlfJlqpIHHKioTLzFoXGhfuwFI-zO0eMKRkpNuHTUh0dkGUJZar2PLYKq5M6DfgfNLB6agS0Ugx-CBYUoQlJVhSHqYISwNOJwCkONApe6FyOxwXaBRjeEjBQAN2K0CmjU2QbICcg2pqQCLa83cQoVJMu0Zk_89PnsDK43U7vb_t3h3AKn1KVaJ2CEufH2N7BIuFGR-Xo_MbiLzt-w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Review+of+pharmacotherapy+for+smoking+cessation+in+patients+with+schizophrenia&rft.jtitle=The+mental+health+clinician&rft.au=Shawen%2C+Avery+E&rft.au=Drayton%2C+Shannon+J&rft.date=2018-03-01&rft.eissn=2168-9709&rft.volume=8&rft.issue=2&rft.spage=78&rft.epage=85&rft_id=info:doi/10.9740%2Fmhc.2018.03.078&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-9709&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-9709&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-9709&client=summon